PharmaShots

APRIL 14, 2023

Ocugen Reports Preliminary Results from the P-I/II Trial of OCU400 for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis Date: Apr 14, 2023 | Tags: Ocugen, OCU400, Retinitis Pigmentosa, Leber Congenital Amaurosis, Clinical Trial, P-I/II Trial Candesant Biomedical Receives the US FDA Clearance of Brella SweatControl Patch for Primary (..)

FDA 40

FDA 40

Pharmaceutical Technology

SEPTEMBER 30, 2022

Spark Therapeutics’ Luxturna, indicated for inherited retinal disease (IRD), was the first gene therapy to be approved, in 2017, with a price tag of $850,000 for each eye. Prior to bluebird's approvals, there were only two FDA-approved gene therapies for inherited conditions on the market.

FDA 115

FDA Insurance 115

Roots Analysis

MARCH 1, 2024

Anti-counterfeiting technologies technologies can be broadly classified under two categories, namely Authentication Technologies and Track & Trace Technologies. Most of them are visible to the naked eye. Track & Trace technologies constitute a separate segment in the anti-counterfeiting technologies market.

Packaging 52

Packaging Labelling 52

pharmaphorum

JANUARY 31, 2023

What people did not understand was that “fast tracking” approval does not limit the rigorous process involved in ensuring that a medication or vaccine is safe for market use. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 52

Viseven

SEPTEMBER 14, 2023

Tracking order status. The lack of transparency is positively correlated with improper security as well, as it becomes problematic for buyers to protect medicines they cannot track. Climate change is another factor, potentially disrupting supplies and contributing to hefty price tags. Determining drug quantities.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52

The Social Pharmacist

AUGUST 5, 2022

Focusing on your website links leads to confusion and spam in the eyes of your target audience. Keep an eye on your pharmacy’s online reputation. Strategize Your Internal Linking and Social Tags for Higher Domain Authority Rating. Adding Social Tags to Your Pharmacy Website. Ready to Start Tracking Domain Authority?

HIPAA 52

HIPAA Customer Service Insurance Labelling 52

The Social Pharmacist

AUGUST 5, 2022

Focusing on your website links leads to confusion and spam in the eyes of your target audience. Keep an eye on your pharmacy’s online reputation. Strategize Your Internal Linking and Social Tags for Higher Domain Authority Rating. Adding Social Tags to Your Pharmacy Website. Ready to Start Tracking Domain Authority?

HIPAA 40

HIPAA Customer Service Insurance Labelling 40